IP Verse

Uniqure Biopharma competitive analysis

Latest publications and patents of Uniqure Biopharma New

Explore the latest publications and patents granted to Uniqure Biopharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Uniqure Biopharma

EP4032979
May 1, 2024Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionGranted And Under Opposition
EP3581650
Dec 28, 2022Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionGranted And Under Opposition
EP2337849
Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionRevoked

Latest patents of Uniqure Biopharma opposed by its competitors

Explore Uniqure Biopharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP4032979
May 1, 2024Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP3581650
Dec 28, 2022Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production1
EP2337849
Jun 13, 2018Factor Ix Polypeptide Mutant, Its Uses And A Method For Its Production5

Latest PTAB cases involving Uniqure Biopharma

Discover the latest PTAB cases involving Uniqure Biopharma, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 3, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Uniqure Biopharma

IPR2021-00928May 11, 2021PFIZERUNIQURE BIOPHARMAFinal Written Decision
IPR2021-00926May 11, 2021PFIZERUNIQURE BIOPHARMAFinal Written Decision
IPR2021-00925May 11, 2021PFIZERUNIQURE BIOPHARMAFinal Written Decision
IPR2020-00388Jan 4, 2020PFIZERUNIQURE BIOPHARMAFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Uniqure Biopharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
UNIQURE BIOPHARMA - 7 - 4Non-Active
BAXALTA519 - - Defensive
GREAVES BREWSTER9 - - - Highly Aggressive
PFIZER51864312Aggressive